INCYTE Corporation (INCY)

HEALTH CARE: PHARMACEUTICALS
SIC: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

1801 AUGUSTINE CUT-OFF WILMINGTON, DE 19803

Incyte is a biopharmaceutical company focused on developing and commercializing proprietary small molecule drugs for oncology and inflammation. Co.'s pipeline includes compounds in several stages, ranging from preclinical to commercialized product. Co.'s compound, JAKAFI (ruxolitinib), also known as INCB18424 and INC424, is an oral Janus associated kinase (JAK) inhibitor used as a treatment for patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF and post-essential thrombocythemia MF. Co. has a second oral JAK1 and JAK2 inhibitor, LY3009104 (INCB28050), which is subject to a collaboration agreement with Eli Lilly and Company.

Data based on most recent fiscal year report
Market Cap17.282 Billion Shares Outstanding211.04 Million Avg Volume2.903 Million
1-Yr BETA vs S&P TR Current Ratio4.01 Quick Ratio3.99
View SEC Filings from INCY instead.
Q3 2018 All Institutions Hedge Funds 1
To trade INCY now:
Filers who had this stock in their top 10: 10 4 (0.39%)
13F Filers holding this stock: 454 68 (6.56%)
Aggregate 13F shares on 09/30/2018: 193.067 Million 50.398 Million
Aggregate 13F shares on 06/30/2018: 202.734 Million 48.802 Million
Percent change: -4.77% 3.27%
Funds creating new positions: 59 20
Funds Adding to an existing position: 171 24
Funds closing out their position: 43 13
Funds reducing their position: 155 16
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding INCY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to

Exclude:

Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

72.1 Thousand total shares from 6 transactions

Exercise Derivative Conversion (M)

70.4 Thousand total shares from 5 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HASTINGS DAVID C

  • Director
0 2019-01-18 0

WENQING YAO EVP, HEAD OF DISCOVERY CHEM

  • Officer
34,409 2019-01-17 5

TROWER PAUL PRINCIPAL ACCOUNTING OFFICER

  • Officer
13,900 2019-01-15 6

BIENAIME JEAN JACQUES CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
469,791 2019-01-14 6

FLANNELLY BARRY P EVP & GENERAL MANAGER US

  • Officer
9,944 2019-01-08 6

GRYSKA DAVID W

  • Director
45,050 2019-01-08 3

SWAIN PAULA J EVP, HUMAN RESOURCES

  • Officer
31,124 2019-01-04 9

HOPPENOT HERVE CHAIRMAN / CEO

  • Officer
  • Director
  • PRESIDENT
240,565 2019-01-04 6

STEIN STEVEN H EVP & CHIEF MEDICAL OFFICER

  • Officer
13,773 2019-01-04 4

IYENGAR VIJAY K EVP GPS, BD, & LICENSING

  • Officer
0 2019-01-04 3

PASQUALE MARIA E EVP & GENERAL COUNSEL

  • Officer
0 2019-01-04 4

BAKER BROS. ADVISORS LP

14159, L.P.

667, L.P.

BAKER BROS. ADVISORS (GP) LLC

BAKER BROTHERS LIFE SCIENCES LP

BAKER FELIX

BAKER JULIAN

  • Director
  • 10% Owner
4,891,505 2019-01-02 3

DE SCHUTTER RICHARD U

  • Director
272,635 2018-12-31 0

DIXON WENDY L

  • Director
10,199 2018-12-31 5

BROOKE PAUL A

  • Director
238,929 2018-12-31 8

FOUSE JACQUALYN A

  • Director
712 2018-12-31 5

EMMENS MATTHEW

  • Director
0 2018-12-31 0

DHANAK DASHYANT EVP & CHIEF SCIENTIFIC OFFICER

  • Officer
0 2018-12-10 2

FRIEDMAN PAUL A CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
161,128 2018-11-20 1

LEVY RICHARD S

  • Director
0 2018-10-03 0

WHITFIELD ROY A

  • Director
201,750 2018-09-27 0

HUBER REID M EVP, CHIEF SCIENTIFIC OFFICER

  • Officer
34,571 2018-07-16 3

CLANCY PAUL J EVP, CHIEF FINANCIAL OFFICER

  • Officer
93,309 2018-07-10 1

DALY JAMES M

  • Director
0 2018-06-20 0

ANDREWS PATRICIA S

  • Director
0 2018-05-18 0

SIEGEL ERIC H. EVP, GENERAL COUNSEL

  • Officer
21,053 2017-09-13 0

CHARDONNET LAURENT

  • VICE PRESIDENT AND TREASURER
2,905 2015-03-30 0

ARIKO BARRY A

  • Director
45,834 2015-03-12 0

BAKER BROS. ADVISORS (GP) LLC

  • Director
  • 10% Owner
0 2013-07-01 0

BAKER BROTHERS LIFE SCIENCES LP

  • Director
12,445,783 2013-06-11 0

14159, L.P.

  • Director
370,839 2013-06-11 0

667, L.P.

  • Director
2,038,937 2013-06-11 0

BAKER JULIAN

BAKER FELIX

BAKER BROS ADVISORS LLC

667, L.P.

BAKER BROTHERS LIFE SCIENCES LP

14159, L.P.

  • Director
  • 10% Owner
15,023,952 2013-06-11 0

BAKER JULIAN

  • Director
  • 10% Owner
0 2013-05-30 0

FBB ASSOCIATES

  • Director
173,897 2012-07-26 0

FBB2 LLC

  • Director
  • 10% Owner
15,110 2012-06-15 0

BAKER BROS ADVISORS LLC

  • 10% Owner
0 2012-04-12 0

BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
2,328,863 2012-03-12 0

14159 CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
57,704 2012-03-12 0

BAKER BIOTECH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
232,011 2012-03-12 0

BAKER BROS. CAPITAL (GP), LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
0 2012-01-27 0

BAKER / TISCH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
450,461 2011-12-30 0

NIBLACK JOHN F

  • Director
0 2011-05-20 0

SCHRECK PATRICIA A EVP, GENERAL COUNSEL

  • Officer
4,500 2011-05-09 0

METCALF BRIAN W CHIEF DRUG DISCOVERY SCIENTIST

  • Officer
66,504 2011-04-11 0

FRIEDMAN STEVEN M. EVP, BIOLOGY & PRECLINICAL DEV

  • Officer
0 2010-05-18 0

KELLER JOHN A CHIEF BUSINESS OFFICER

  • Officer
0 2008-02-08 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

WENQING YAO - Officer EVP, HEAD OF DISCOVERY CHEM

2019-01-17 M 15,354 $17.79 a 49,763 34,409.00 direct

WENQING YAO - Officer EVP, HEAD OF DISCOVERY CHEM

2019-01-17 M 15,354 d 0 34,409.00 direct

WENQING YAO - Officer EVP, HEAD OF DISCOVERY CHEM

2019-01-17 S 15,354 $77.61 d 34,409 34,409.00 direct

TROWER PAUL - Officer PRINCIPAL ACCOUNTING OFFICER

2019-01-15 S 5,813 $75.00 d 13,900 13,900.00 direct

TROWER PAUL - Officer PRINCIPAL ACCOUNTING OFFICER

2019-01-15 M 5,813 $17.79 a 19,713 13,900.00 direct

TROWER PAUL - Officer PRINCIPAL ACCOUNTING OFFICER

2019-01-15 M 5,813 d 0 13,900.00 direct

FLANNELLY BARRY P - Officer EVP & GENERAL MANAGER US

2019-01-08 S 1,714 $75.56 d 9,944 9,944.00 direct

TROWER PAUL - Officer PRINCIPAL ACCOUNTING OFFICER

2019-01-07 M 9,187 d 0 13,900.00 direct

TROWER PAUL - Officer PRINCIPAL ACCOUNTING OFFICER

2019-01-07 M 9,187 $17.79 a 23,359 13,900.00 direct

WENQING YAO - Officer EVP, HEAD OF DISCOVERY CHEM

2019-01-07 M 10,000 $17.79 a 45,217 34,409.00 direct

TROWER PAUL - Officer PRINCIPAL ACCOUNTING OFFICER

2019-01-07 F 272 $74.21 d 13,900 13,900.00 direct

WENQING YAO - Officer EVP, HEAD OF DISCOVERY CHEM

2019-01-07 F 808 $74.21 d 34,409 34,409.00 direct

STEIN STEVEN H - Officer EVP & CHIEF MEDICAL OFFICER

2019-01-07 F 847 $74.21 d 13,773 13,773.00 direct

WENQING YAO - Officer EVP, HEAD OF DISCOVERY CHEM

2019-01-07 M 10,000 d 15,354 34,409.00 direct

HOPPENOT HERVE - Director - Officer CHAIRMAN / CEO PRESIDENT

2019-01-07 F 4,604 $74.21 d 152,532 240,565.00 direct

TROWER PAUL - Officer PRINCIPAL ACCOUNTING OFFICER

2019-01-07 S 9,187 $75.00 d 14,172 13,900.00 direct

WENQING YAO - Officer EVP, HEAD OF DISCOVERY CHEM

2019-01-07 S 10,000 $75.00 d 35,217 34,409.00 direct

SWAIN PAULA J - Officer EVP, HUMAN RESOURCES

2019-01-07 F 1,200 $74.21 d 31,124 31,124.00 direct

FLANNELLY BARRY P - Officer EVP & GENERAL MANAGER US

2019-01-07 F 896 $74.21 d 11,658 11,658.00 direct

TROWER PAUL - Officer PRINCIPAL ACCOUNTING OFFICER

2019-01-04 A 6,298 a 6,298 13,900.00 direct

WENQING YAO - Officer EVP, HEAD OF DISCOVERY CHEM

2019-01-04 A 22,772 a 22,772 34,409.00 direct

SWAIN PAULA J - Officer EVP, HUMAN RESOURCES

2019-01-04 A 31,552 a 31,552 31,124.00 direct

STEIN STEVEN H - Officer EVP & CHIEF MEDICAL OFFICER

2019-01-04 A 22,772 a 22,772 13,773.00 direct

FLANNELLY BARRY P - Officer EVP & GENERAL MANAGER US

2019-01-04 A 63,105 a 63,105 11,658.00 direct

SWAIN PAULA J - Officer EVP, HUMAN RESOURCES

2019-01-04 S 30,000 $70.00 d 32,324 31,124.00 direct

HOPPENOT HERVE - Director - Officer CHAIRMAN / CEO PRESIDENT

2019-01-04 A 88,558 a 88,558 240,565.00 direct

IYENGAR VIJAY K - Officer EVP GPS, BD, & LICENSING

2019-01-04 A 31,552 a 31,552 0.00 direct

SWAIN PAULA J - Officer EVP, HUMAN RESOURCES

2019-01-04 A 22,772 a 22,772 31,124.00 direct

FLANNELLY BARRY P - Officer EVP & GENERAL MANAGER US

2019-01-04 A 22,772 a 22,772 11,658.00 direct

TROWER PAUL - Officer PRINCIPAL ACCOUNTING OFFICER

2019-01-04 A 7,377 a 7,377 13,900.00 direct

SWAIN PAULA J - Officer EVP, HUMAN RESOURCES

2019-01-04 M 30,000 d 21,782 31,124.00 direct

SWAIN PAULA J - Officer EVP, HUMAN RESOURCES

2019-01-04 M 30,000 $18.32 a 62,324 31,124.00 direct

IYENGAR VIJAY K - Officer EVP GPS, BD, & LICENSING

2019-01-04 A 22,772 a 22,772 0.00 direct

PASQUALE MARIA E - Officer EVP & GENERAL COUNSEL

2019-01-04 A 22,772 a 22,772 0.00 direct

HOPPENOT HERVE - Director - Officer CHAIRMAN / CEO PRESIDENT

2019-01-02 F 27,630 $63.56 d 157,136 245,169.00 direct

DIXON WENDY L - Director

2018-12-31 A 255 $63.59 a 10,199 10,199.00 direct

BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

14159, L.P. - Director - > 10% Owner see footnotes

667, L.P. - Director - > 10% Owner see footnotes

BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

BAKER FELIX - Director - > 10% Owner see footnotes

BAKER JULIAN - Director - > 10% Owner see footnotes

2018-12-31 A 298 $63.59 a 4,408,264 34,641,010.00 indirect

BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

14159, L.P. - Director - > 10% Owner see footnotes

667, L.P. - Director - > 10% Owner see footnotes

BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

BAKER FELIX - Director - > 10% Owner see footnotes

BAKER JULIAN - Director - > 10% Owner see footnotes

2018-12-31 A 298 $63.59 a 810,862 34,641,010.00 indirect

BIENAIME JEAN JACQUES - Director

2018-12-31 A 228 $63.59 a 6,896 6,896.00 direct

FOUSE JACQUALYN A - Director

2018-12-31 A 196 $63.59 a 712 712.00 direct

BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

14159, L.P. - Director - > 10% Owner see footnotes

667, L.P. - Director - > 10% Owner see footnotes

BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

BAKER FELIX - Director - > 10% Owner see footnotes

BAKER JULIAN - Director - > 10% Owner see footnotes

2018-12-31 A 298 $63.59 a 29,268,793 34,641,010.00 indirect

BROOKE PAUL A - Director

2018-12-31 A 373 $63.59 a 198,929 238,929.00 direct

DHANAK DASHYANT - Officer EVP & CHIEF SCIENTIFIC OFFICER

2018-12-10 A 6,878 a 6,878 6,878.00 direct

DHANAK DASHYANT - Officer EVP & CHIEF SCIENTIFIC OFFICER

2018-12-10 A 48,403 a 48,403 6,878.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments